路透10月30日 - 以下是部分加拿大报纸的热门新闻。路透未对这些报道进行核实，也不保证其准确性。
全球邮报
** 印度制药巨头雷迪博士实验室（Dr. Reddy's Laboratories）称，加拿大卫生部已拒绝了其生产仿制药 semaglutide 的申请，这对该公司来说是一个挫折，因为它有望成为 Ozempic 2026 年上市的首批仿制药 (link) 竞争对手之一。
** 前银行业高管戈登-尼克松（Gordon Nixon (link)）将离开其长期担任的电信公司BCEBCE.TO董事长职位，加入美国金融科技公司FiservFI.N董事会。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.